Shares of Allakos (NASDAQ: ALLK) plunged nearly 90% today after the company reported Phase 3 data for ENIGMA 2 study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE